You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表现》海吉亚医疗(06078.HK)暗盘收23.5元 高上市价27%
阿思达克 06-26 18:33
根据辉立交易平台显示,下周一(29日)挂牌的海吉亚医疗(06078.HK)暗盘高开19%报22元获承接,最高见24.5元,收报23.5元,较上市价18.5元,高27%或5元,成交822万股,涉资1.91亿元。不计手续费,每手200股,账面赚1,000元。

根据弗若斯特沙利文资料,按2019年放疗相关服务产生收入计,海吉亚是内地最大肿瘤医疗集团。是次来港上市共发售1.2亿股,并已引入包括高瓴资本、奥博资本及南方基金等9名基石投资者,合共认购5,990.36万股,其中10%公开发售获逾607倍超购,已启动回拨机制占比增至50%,认购一手中签率仅8.8%,股份以招股范围(17-18.5元)上限定价,料集资净额约20.72亿元,主要用作升级现有医院和设立4间新医院及收购医院等。上市联席保荐人分别为大摩及海通国际。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account